Publications by authors named "Beth Cywin"

Claim this Profile
C
Corrigendum to "Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years" [Vaccine 40 (2022) 4190-4198].
Gurunadh R Chichili, Ronald Smulders, Vicki Santos, Beth Cywin, Laura Kovanda

Vaccine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.
Gurunadh R Chichili, Ronald Smulders, Vicki Santos, Beth Cywin, Laura Kovanda

Vaccine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.
Per Ljungman, Arancha Bermudez, Aaron C Logan, Mohamed A Kharfan-Dabaja, Patrice Chevallier, Beth Cywin

EClinicalMedicine· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis